Publications

  1. Moreno-Luna LE, Yang JD, Sanchez W, Paz-Fumagalli R, Harnois DM, Mettler TA, Gansen DN, de Groen PC, Lazaridis KN, Narayanan Menon KV, Larusso NF, Alberts SR, Gores GJ, Fleming CJ, Slettedahl SW, Harmsen WS, Therneau TM, Wiseman GA, Andrews JC, Roberts Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2013 Jun; 36(3):714-23. Epub 2012 Oct 24. 2279057
    View PubMed
  2. Darwish Murad S, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM, Botha JF, Mezrich JD, Chapman WC, Schwartz JJ, Hong JC, Emond JC, Jeon H, Rosen CB, Gores GJ, Heimbach JK. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology. 2012 Jul; 143(1):88-98.e3; quiz e14. Epub 2012 Apr 12. 2243850
    View PubMed
  3. Panjala C, Nguyen JH, Al-Hajjaj AN, Rosser BA, Nakhleh RE, Bridges MD, Ko SJ, Buskirk SJ, Kim GP, Harnois DM. Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma. Liver Transpl. 2012 May; 18(5):594-601. 2209925
    View PubMed
  4. Imam MH, Sinakos E, Gossard AA, Kowdley KV, Luketic VA, Edwyn Harrison M, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, DeCook AC, Enders F, Lindor KD. High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis. Aliment Pharmacol Ther. 2011 Nov; 34(10):1185-92. Epub 2011 Sep 29. 2196779
    View PubMed
  5. Eaton JE, Silveira MG, Pardi DS, Sinakos E, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Lindor KD. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Am J Gastroenterol. 2011 Sep; 106(9):1638-45. Epub 2011 May 10. 2163894
    View PubMed
  6. Taner CB, Bulatao IG, Keaveny AP, Willingham DL, Pungpapong S, Perry DK, Rosser BG, Harnois DM, Aranda-Michel J, Nguyen JH. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus. Liver Transpl. 2011 Jun; 17(6):641-9. 2166799
    View PubMed
  7. Taner CB, Balci D, Willingham DL, Keaveny AP, Rosser BG, Canabal JM, Shine TS, Harnois DM, Kramer DJ, Nguyen JH. Long-term outcomes after third liver transplant. Exp Clin Transplant. 2011 Apr; 9(2):98-104. 2160267
    View PubMed
  8. Begum R, Harnois D, Satyanarayana R, Krishna M, Halling KC, Kim GP, Nguyen JH, Keaveny AP. Retransplantation for donor-derived neuroendocrine tumor. Liver Transpl. 2011 Jan; 17(1):83-7. 2143288
    View PubMed
  9. Albright JB, Bonatti H, Stauffer J, Dickson RC, Nguyen J, Harnois D, Jeanpierre C, Hinder R, Steers J, Chua H, Aranda-Michel J. Colorectal and anal neoplasms following liver transplantation. Colorectal Dis. 2010 Jul; 12(7):657-66. 1937955
    View PubMed
  10. Panjala C, Senecal DL, Bridges MD, Kim GP, Nakhleh RE, Nguyen JH, Harnois DM. The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma. Am J Transplant. 2010 May; 10(5):1263-7. 1997700
    View PubMed
  11. Treeprasertsuk S, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, Schmoll J, Hoskin T, Thapa P, Enders F, Lindor KD. The predictors of the presence of varices in patients with primary sclerosing cholangitis. Hepatology. 2010 Apr; 51(4):1302-10. 1978223
    View PubMed
  12. Hughes CB, Dickson RC, Krishna M, Willingham DL, Satyanarayana R, Harnois DM, Keaveny AP, Rosser B, Aranda-Michel J, Kramer DJ, Hellinger W, Mendez J. HCV recurrence in HIV-infected patients after liver transplant. J Int Assoc Physicians AIDS Care (Chic). 2010 Mar-Apr; 9(2):87-93. Epub 2010 Mar 31. 1994100
    View PubMed
  13. Stauffer JA, Steers JL, Bonatti H, Dougherty MK, Aranda-Michel J, Dickson RC, Harnois DM, Nguyen JH. Liver transplantation and pancreatic resection: a single-center experience and a review of the literature. Liver Transpl. 2009 Dec; 15(12):1728-37. 1973376
    View PubMed
  14. Aduen JF, Sujay B, Dickson RC, Heckman MG, Hewitt WR, Stapelfeldt WH, Steers JL, Harnois DM, Kramer DJ. Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years. Mayo Clin Proc. 2009 Nov; 84(11):973-8. 1970484
    View PubMed
  15. Grewal HP, Willingham DL, Nguyen J, Hewitt WR, Taner BC, Cornell D, Rosser BG, Keaveny AP, Aranda-Michel J, Satyanarayana R, Harnois D, Dickson RC, Kramer DJ, Hughes CB. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transpl. 2009 Sep; 15(9):1028-35. 1959561
    View PubMed
  16. Lindor KD, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, Mooney J, Sargeant C, Braaten J, Bernard T, King D, Miceli E, Schmoll J, Hoskin T, Thapa P, Enders F. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology. 2009 Sep; 50(3):808-14. 1952590
    View PubMed
  17. Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, Reddy KR, Harnois D, Llovet JM, Normolle D, Dalhgren J, Chia D, Lok AS, Wagner PD, Srivastava S, Schwartz M. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology. 2009 Jul; 137(1):110-8. Epub 2009 Apr 09. 1965473
    View PubMed
  18. Nguyen JH, Bonatti H, Dickson RC, Hewitt WR, Grewal HP, Willingham DL, Harnois DM, Schmitt TM, Machicao VI, Ghabril MS, Keaveny AP, Aranda-Michel J, Satyanarayana R, Rosser BG, Hinder RA, Steers JL, Hughes CB. Long-term outcomes of donation after cardiac death liver allografts from a single center. Clin Transplant. 2009 Mar-Apr; 23(2):168-73. Epub 2009 Feb 11. 1925084
    View PubMed
  19. Nguyen JH, Dickson RC, Harnois DM. A decade of liver transplantation at Mayo Clinic in Florida. Clin Transpl. 2008; 127-35. 1959674
    View PubMed
  20. Ghabril M, Dickson RC, Machicao VI, Aranda-Michel J, Keaveny A, Rosser B, Bonatti H, Krishna M, Yataco M, Satyanarayana R, Harnois D, Hewitt W, Willingham DD, Grewal H, Hughes CB, Nguyen J. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival. Liver Transpl. 2007 Dec; 13(12):1717-27. 1858880
    View PubMed
  21. Pungpapong S, Keaveny A, Raimondo M, Dickson R, Woodward T, Harnois D, Wallace M. Accuracy and interobserver agreement of small-caliber vs. conventional esophagogastroduodenoscopy for evaluating esophageal varices. Endoscopy. 2007 Aug; 39(8):673-80. Epub 2007 Jun 22. 1834764
    View PubMed
  22. Nields WW, Bonatti H, Harnois D, Hinder R, Nguyen J, Dickson RC, Aranda-Michel J, Randle HW. Squamous cell cancer, basal cell cancer and melanoma in a single liver transplant recipient. Eur. Surg. Acta Chir. Austriaca. 2007; 39(5):321-2. 1975697
    View PubMed
  23. Hellinger WC, Bonatti H, Machicao VI, Yao JD, Brumble LM, Alvarez S, Weigand SD, Dickson RC, Harnois DM, Spivey JR, Stapelfeldt WH, Hughes CB, Nguyen JH, Steers JL. Effect of antiviral chemoprophylaxis on adverse clinical outcomes associated with cytomegalovirus after liver transplantation. Mayo Clin Proc. 2006 Aug; 81(8):1029-33. 1775759
    View PubMed
  24. Pungpapong S, Alvarez S, Hellinger WC, Kramer DJ, Willingham DL, Mendez JC, Nguyen JH, Hewitt WR, Aranda-Michel J, Harnois DM, Rosser BG, Hughes CB, Grewal HP, Satyanarayana R, Dickson RC, Steers JL, Keaveny AP. Peritonitis after liver transplantation: Incidence, risk factors, microbiology profiles, and outcome. Liver Transpl. 2006 Aug; 12(8):1244-52. 1775770
    View PubMed
  25. Hellinger WC, Bonatti H, Yao JD, Alvarez S, Brumble LM, Keating MR, Mendez JC, Kramer DJ, Dickson RC, Harnois DM, Spivey JR, Hughes CB, Nguyen JH, Steers JL. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation. Liver Transpl. 2005 Jun; 11(6):656-62. 1720424
    View PubMed
  26. Levy C, Harnois DM, Angulo P, Jorgensen R, Lindor KD. Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study. Liver International. 2005 Feb; 25(1):117-21. 1694419
    View PubMed
  27. Schmitt TM, Hughes CB, Bonatti H, Harnois DM, Nguyen JH, Dickson RC, Spivey JR, Steers JL. Gallbladder cancer and liver transplantation. Transpl Int. 2005 Jan; 18(1):52-5. 1694040
    View PubMed
  28. Aqel BA, Machicao V, Rosser B, Satyanarayana R, Harnois DM, Dickson RC. Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis. J Clin Gastroenterol. 2004 Oct; 38(9):805-9. 1667489
    View PubMed
  29. Bridges MD, May GR, Harnois DM. Diagnosing biliary complications of orthotopic liver transplantation with mangafodipir trisodium-enhanced MR cholangiography: comparison with conventional MR cholangiography. AJR Am J Roentgenol. 2004 Jun; 182(6):1497-504. 1647055
    View PubMed
  30. Machicao VI, Bonatti H, Krishna M, Aqel BA, Lukens FJ, Nguyen JH, Rosser BG, Satyanarayana R, Grewal HP, Hewitt WR, Harnois DM, Crook JE, Steers JL, Dickson RC. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation. 2004 Jan 15; 77(1):84-92. 1519842
    View PubMed
  31. Scolapio JS, DeArment J, Hurley DL, Romano M, Harnois D, Weigand SD. Influence of tacrolimus and short-duration prednisone on bone mineral density following liver transplantation. JPEN J Parenter Enteral Nutr 2003 Nov-Dec; 27(6):427-32. 1646973
    View PubMed
  32. Chabolla DR, Harnois DM, Meschia JF. Levetiracetam monotherapy for liver transplant patients with seizures. Transplant Proc. 2003 Jun; 35(4):1480-1. 1404290
    View PubMed
  33. Hellinger WC, Yao JD, Alvarez S, Blair JE, Cawley JJ, Paya CV, O'Brien PC, Spivey JR, Dickson RC, Harnois DM, Douglas DD, Hughes CB, Nguyen JH, Mulligan DC, Steers JL. A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation. 2002 Jun 27; 73(12):1904-9. 1314758
    View PubMed
  34. Harnois DM, Angulo P, Jorgensen RA, LaRusso NF, Lindor KD. High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis. Am J Gastroenterol. 2001 May; 96(5):1558-62. 1004940
    View PubMed
  35. Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol. 2000 Jan; 95(1):204-7. 127187
    View PubMed
  36. Harnois DM, Steers J, Andrews JC, Rubin JC, Pitot HC, Burgart L, Wiesner RH, Gores GJ. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg. 1999 May; 5(3):192-9. 115277
    View PubMed
  37. Harnois DM, Gores GJ, Ludwig J, Steers JL, Larusso NF, Wiesner RH. Are patients with cirrhotic-stage primary sclerosing cholangitis at risk for the development of hepatocelluar carcinoma? Review series: Hepatitis. 1999:8-9. 1321243
  38. Harnois DM, Que FG, Celli A, LaRusso NF, Gores GJ. Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line. Hepatology. 1997 Oct; 26(4):884-90. 100440
    View PubMed
  39. Harnois DM, Gores GJ, Ludwig J, Steers JL, LaRusso NF, Wiesner RH. Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? J Hepatol. 1997 Sep; 27(3):512-6. 99976
    View PubMed
  40. Harnois DM, Lindor KD. Primary sclerosing cholangitis: evolving concepts in diagnosis and treatment. Dig Dis. 1997 Jan-Apr; 15(1-2):23-41. 101980
    View PubMed